Numerof https://validator.w3.org/feed/docs/rss2.html Our Clients The Capability Gap: Why Pharma Companies Are Falling Behind in an Evidence-Driven Market Numerof Appoints Former Chief Commercial Officer Ronald Kierpa as Senior Advisor The Problems of Continuity of Care Have Intensified—Another Reason Why Hospitals Need a New Business Model Hospital Costs and Accountability Under Fire: Key Takeaways from the House Ways and Means Hearing Pharma’s Commercial Reset: How the Industry is Rewriting the Model What the AstraZeneca-BMS Merger Talks Reveal About the Future of Market Access <I>BioSpace</I> Interviews Numerof on Commissioner’s National Priority Vouchers <I>Fierce Biotech</I> Interviews Numerof on Clinical Trial Prediction Markets <I>PharmaVoice</I> Interviews Numerof on Specialized R&D in Pharma <I>Health Payer Specialist</I> Interviews Numerof on Cigna’s Evolving Strategy Design Principles for Value-Based Solutions Why the Old Drug Development Model Is Breaking Down — And What Comes Next After Vinay Prasad: Rethinking Evidence, Access and the Future of FDA Regulation Potential 340B Transformation Strategic Launch Sequencing (SLS) The Financial Superstorm Coming for the Pharma Industry National Media Coverage of Numerof’s Commercial Model Survey <I>Virginia Economic Review</I> Interviews Numerof on Reshoring Drug Manufacturing <I>BioPharma Dive</I> Interviews Numerof on Vinay Prasad’s Departure from the FDA Numerof Featured in <i>Medical Economics</i> on CMS’s WISeR Model <i>PharmaVoice</i> Interviews Numerof on AstraZeneca-BMS Merger Talks Why Changes to the Healthcare Business Model Have Stalled for Decades Blog Numerof Appoints Former Biopharma Market Access Leader Laurent Carter as Senior Advisor Beyond the Patent Cliff: Why Pharma’s Layoffs Signal a Deeper Strategic Shift Home What Senator Bill Cassidy’s 340B Proposal Reveals About America’s Healthcare Business Model The New Product Development Landscape: Navigating the Challenges <i>MedCity News</i> Interviews Numerof on Talkspace Acquisition <i>Health Payer Specialist</i> Interviews Numerof on Cigna CEO’s Strategy <I>PharmaVoice</I> Interviews Numerof on Purdue Pharma Settlement Numerof Featured in <i>DC Journal</i> on Accountability in Healthcare <i>MedCity News</i> Interviews Numerof on CMS’s WISeR Model Healthcare Delivery Organizations Need to Demonstrate Value. Here’s How to Do It Beyond Dissatisfaction: A Framework for Healthcare Transformation <i>MedCity News</i> Interviews Numerof on Hinge Health Acquisition of Cylinder What the Rumored AstraZeneca-Bristol Myers Squibb Merger Suggests About Pharma’s Future Ron Kierpa Laurent Carter, MBA Susan Alpert, PhD, MD <i>MedCity News</i> Interviews Numerof on Hims & Hers – Novo Nordisk Partnership Senior Analyst – Life Sciences Practice Accelerate Your Evidence Planning Process and Cut Your Time to Market <I>PharmaVoice</I> Interviews Numerof on FDA’s CRL Push <I> Healthcare Brew </I> Interviews Numerof on CVS Health’s Agentic AI Platform Matt Chatmon <i>Financial Times</i> Interviews Numerof on Cigna’s CEO Transition Narrow Labels as the Solution to a Shorter Commercial Runway <i>Chief Healthcare Executive</i> Interviews Numerof on Rising Healthcare Costs